Period Ending | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 | Apr 29, 2012 |
---|
Total Revenue
|
28,359,000
|
29,959,000
|
29,669,000
|
30,693,000
| Cost of Revenue | 22,029,000 | 22,711,000 | 22,820,000 | 23,541,000 | |
Gross Profit
|
6,330,000
|
7,248,000
|
6,849,000
|
7,152,000
| |
|
Operating Expenses |
|
Research Development | 794,000 | 909,000 | 854,000 | 850,000 |
|
Selling General and Administrative | 3,300,000 | 3,227,000 | 3,366,000 | 3,540,000 |
|
Non Recurring | 134,000 | 9,228,000 | 10,986,000 | 70,000 |
|
Others | 350,000 | 372,000 | 476,000 | 470,000 |
|
|
|
Total Operating Expenses | 4,578,000 | 13,736,000 | 15,682,000 | 4,930,000 | | |
Operating Income or Loss
|
1,752,000
|
(6,488,000)
|
(8,833,000)
|
2,222,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,573,000 | (6,488,000) | (8,833,000) | 2,443,000 |
|
Interest Expense |
-
| 188,000 | 224,000 | 464,000 |
|
Income Before Tax | 1,573,000 | (6,676,000) | (9,057,000) | 1,979,000 |
|
Income Tax Expense | 341,000 | 178,000 | (200,000) | 386,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,232,000 | (6,854,000) | (8,857,000) | 1,593,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,232,000
|
(6,854,000)
|
(8,857,000)
|
1,593,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,232,000
|
(6,854,000)
|
(8,857,000)
|
1,593,000
|
|